Allegro Microsystems Inc (ALGM) News & EventsALGMNews & EventsAllegro Microsystems Inc

Sees Q2 Revenue of $265M-$275M

Sees Q2 revenue $265M-$275M, consensus $263.82M.

Sera Prognostics Joins $10.4M ARPA-H Research Program

Sera Prognostics (SERA) announced its participation in a multi-institutional research program that was awarded up to $10.4M by the Advanced Research Projects Agency for Health, or ARPA-H, to develop a novel point-of-care diagnostic test designed to improve the safety of labor and delivery. The award, part of ARPA-H's Making Obstetrics Care Smart program, supports a collaboration led by researchers at the University of California San Diego alongside Sera Prognostics and Allegro MicroSystems (ALGM). The program aims to develop new technologies that enable more precise, data-driven decision-making during childbirth. The research team is working to develop a diagnostic approach that can assess the risk of low fetal oxygen levels from a small maternal blood sample. The program will explore the integration of identified biomarkers into a rapid, point-of-care testing platform capable of delivering results from a small maternal blood sample.

Allegro MicroSystems Appoints Brian White as Independent Director

Allegro MicroSystems announced the appointment of Brian White to Allegro's Board of Directors as an independent director. White's appointment was effective on June 17, 2026.